OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Zahra Sadat Hashemi, et al.
Pilot and Feasibility Studies (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Zahra Sadat Hashemi, et al.
Pilot and Feasibility Studies (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients
Abdulaziz Alamri
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Abdulaziz Alamri
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients
Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Maryam Barkhordar, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Maryam Barkhordar, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Natural Killer Cell‐Derived Extracellular Vesicles as Potential Anti‐Viral Nanomaterials
Siyoung A. Lim, Nathan Ho, Sophia Chen, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 19
Closed Access | Times Cited: 2
Siyoung A. Lim, Nathan Ho, Sophia Chen, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 19
Closed Access | Times Cited: 2
Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro
Minna Sivonen, Katja A. Puttonen, Sara Wojciechowski, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Minna Sivonen, Katja A. Puttonen, Sara Wojciechowski, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Characterization of an engineered ACE2 protein for its improved biological features and its transduction into MSCs: A novel approach to combat COVID-19 infection
Zahra Sadat Hashemi, Saeed Khalili, Mahdieh Shokrollahi Barough, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134066-134066
Closed Access
Zahra Sadat Hashemi, Saeed Khalili, Mahdieh Shokrollahi Barough, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134066-134066
Closed Access
A Phase I Clinical Trial to Evaluate the Safety of NK cells in COVID-19 (RELEASE).
Clara Hernández-Blanco, Karima Al‐Akioui‐Sanz, Lara Herrera, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111698-111698
Open Access
Clara Hernández-Blanco, Karima Al‐Akioui‐Sanz, Lara Herrera, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111698-111698
Open Access
